Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab

BACKGROUND: Preliminary evidence indicates that early tumor shrinkage (ETS) following immune checkpoint inhibitor (ICI) initiation may be associated with survival outcomes in patients with advanced melanoma. ETS has not been explored as a biomarker of survival outcomes or patient-reported outcomes i...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunother Cancer
Main Authors: Hopkins, Ashley M, Kichenadasse, Ganessan, Karapetis, Chris S, Rowland, Andrew, Sorich, Michael J
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2020
Fag:
Immunotherapy Biomarkers
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279663/
https://ncbi.nlm.nih.gov/pubmed/32503948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000500
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker